Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Blue light could help treat canine ear infections, study finds
Antibiotic resistance can make treating ear infections difficult.
Researchers found the treatment killed antibiotic-resistant bacteria.

A new study has suggested that blue light could be used to treat canine ear infections that aren't responding to antibiotics.

The researchers, from the University of Nottingham and the University of Birmingham, found that blue light could destroy antibiotic-resistant strains of the bacteria Pseudomonas aeruginosa.

The effectiveness of the treatment was even greater when combined with the antibiotic enrofloxacin.

Ear infections are one of the most common conditions seen in dogs. The condition affects up to 20 per cent of dogs globally. In 2016, it was the second most common diagnosis for dogs in the UK.

The researchers tested the effectiveness of using blue light as a treatment on six strains of P. aeruginosa isolated from dogs with otitis externa.

The light produces a chemical reaction within microbial cells, creating reactive oxygen species that can ultimately cause cell death. Different wavelengths of blue light were tested both alone and in combination with enrofloxacin.

The scientists found that some of the frequencies of blue light killed at least 99 per cent of the bacteria. The treatment reduced viable counts of Pseudomonas both with and without enrofloxacin, but the most effective results were achieved when used in combination with the antibiotic.

Following the success of the study, the researchers plan to test blue light treatment against a larger range of clinical Pseudomonas strains. Ultimately, they hope to be able to develop a simple method for using the treatment on dogs in clinics.

Robert Atterbury, associate professor in microbiology at the University of Nottingham, said: “Antibiotic resistance is a growing problem in both people and animals, including their pets. Pseudomonas ear infections in dogs are often very difficult to treat long-term because of this resistance.  
 
“The possibility of a new, non-invasive treatment for this condition, based on exposure to antimicrobial frequencies of blue light, has the potential to transform outcomes for pets and avoid the costly and difficult surgery which may ultimately be required otherwise.”

The study has been published in the journal Frontiers in Microbiology.

Image © Shutterstock

Become a member or log in to add this story to your CPD history

Vets launch new podcast for pet owners

News Story 1
 Two independent vets have launched a podcast to help owners strengthen their bond with pets. Dr Maggie Roberts and Dr Vanessa Howie, who have worked in both veterinary practice and major charities, are keen to use their experience to enable people to give pets a better life.

The venture, called Vets Talking Pets, provides advice and information on a range of topics, including how to select a suitable pet, where to obtain them and how to get the best out of your vet. Maggie and Vanessa will also discuss sensitive subjects, including end-of-life care, raw food diets and the cost of veterinary care.

The podcast can be found on all the usual podcast sites, including Podbean, Apple, Amazon Music and YouTube. 

Click here for more...
News Shorts
VMD issues guidance on AVM-GSL packaging

The Veterinary Medicines Directorate (VMD) has shared advice on its requirements for medicines considered AVM-GSL.

The guidance explains the information that should be on the outer package, and sets out the typical maximum pack size for an AVM-GSL product. It also describes the user-friendly language, structure and phrases required on packaging and product leaflets.

AVM-GSL products do not require discussion between the purchaser and a veterinary professional. This means that clear product information is needed to support sales choices.

The information will be useful for submitting new products to the AVM-GSL category and lowering the distribution category of products from NFA-VPS to AVM-GSL.

The VMD's guidance can be accessed here.